Your search results are below. For a different search, enter another term below and click on the "Search" button:
-
481. Fight CRC hosting symposium on early-onset CRC
Fight Colorectal Cancer is holding a virtual symposium June 11 to discuss the rising incidence rate of early-onset colorectal cancer. Any CRC case in a patient under 50 years old is considered early-onset. ...11 June 2020 -
482. Seattle Cancer Care Alliance opens GI cancer clinic
... rooms that allow patients to receive all their medical oncology care in one room instead of having to move throughout the building. SCCA-affiliated clinicians will treat colorectal, pancreatic, liver ...03 June 2020 -
483. IBD, celiac disease have common connection & more: 5 GI industry key notes
... a common connection. Read more. Modernizing Medicine's integrated payment processing platform, Modmed Pay, is now available to medical practices. Early diagnostic screening for colorectal cancer continues ...27 May 2020 -
484. Long-term CRC risk drops after single negative colonoscopy
A negative screening colonoscopy led to reduced colorectal cancer incidence and mortality rates for up to 17.4 years, according to a study published in the Annals of Internal Medicine and reported on in ...27 May 2020 -
485. Study further validates effectiveness of early CRC screening — 3 insights
Early diagnostic screening for colorectal cancer continues to be essential in reducing CRC-related mortality rate, according to Pharmacy Times. Three things to know: 1. CRC has a 64.4 percent five-year ...20 May 2020 -
486. How to reopen your endoscopy center
... elective cases like screening for colorectal cancer, Barrett's esophagus, gastric intestinal metaplasia, and bariatric procedures when appropriate. Before performing any case, centers should screen patients ...13 May 2020 -
487. How Cologuard compares to FIT & more: 6 GI industry key notes
... patients. Read more. CellMax Life released results from its U.S. study of the FirstSight blood test that revealed the test detected colorectal cancer with 100 percent sensitivity at 90 percent specificity. ...06 May 2020 -
488. Cologuard may be more applicable option for Medicare population than FIT — 4 insight
... the CRC-AIM model to see how a Medicare population would use a triennial multi-target stool DNA test, Cologuard, compared to annual FIT testing. The model uses natural history and colorectal cancer screening ...05 May 2020 -
489. Initial CRC blood test results show promise
CellMax Life released results from its U.S. study of the FirstSight blood test that revealed the test detected colorectal cancer with 100 percent sensitivity at 90 percent specificity. Researchers ...04 May 2020 -
490. Liquid biopsy tests, conventional screening for cancer could present complete picture
... a 99.6 percent specificity rate. The blood test initially detected the following cancers: lymphomas (two), colorectal (two), appendix (one), uterine (two), thyroid (one), kidney (one), lung (nine), ...29 April 2020 -
491. More early-onset CRC cases could be caught by examining family history
Clinicians can help catch early-onset colorectal cancer by consistently screening and recording a patient's family history and proceeding with preventive screening when appropriate, according to a new set ...21 April 2020 -
492. A new PE platform explained, GI thoughts on Cologuard & more: 5 GI industry key notes
... sensitivity and 87 percent specificity rates for detecting colorectal cancer, it remains divisive in the medical community. Here, we present viewpoints from two gastroenterologists on Cologuard, reconnect ...15 April 2020 -
493. 4 gastroenterologists share their thoughts on Exact Sciences' Cologuard
Exact Sciences completed 1.69 million Cologuard tests in 2019, and while the test was found to have 92 percent sensitivity and 87 percent specificity rates for detecting colorectal cancer, it remains divisive ...09 April 2020 -
494. COVID-19 updates for gastroenterologists & more: 7 GI company key notes
... Task Force made a series of recommendations around endoscopic removal of colorectal cancer lesions. Read more. The FDA warned clinicians the SARS-CoV-2 virus, which causes COVID-19, may be transmitted ...01 April 2020 -
495. US task force makes recommendations on endoscopic removal of CRC lesions
The U.S. Multi-Society Task Force made a series of recommendations around endoscopic removal of colorectal cancer lesions in the March issue of The American Journal of Gastroenterology. . The ...31 March 2020 -
496. 15 ASC-focused articles that aren't about COVID-19
... testing kits alone — 3 insights A Louisiana gastroenterologist warned that at-home colorectal cancer testing kits may not be enough for diagnosing the disease. 9. Physician shareholders of Connecticut ...25 March 2020 -
497. Any polyp presence raises CRC risk
Patients with polyps had a higher risk of developing colorectal cancer than the general population, according to a study published in Lancet Gastroenterology & Hepatology. Medpage Today reported ...25 March 2020 -
498. Baseline colonoscopy results predict 10-year outcomes
... with high-grade dysplasia or colorectal cancer received individualized care. What they found: 1. About 146 patients among all baseline colonoscopy groups had at least one advanced neoplasia over 10 ...20 March 2020 -
499. Gastroenterologist advises against home testing kits alone — 3 insights
A Louisiana gastroenterologist warned that at-home colorectal cancer testing kits may not be enough for diagnosing the disease, local ABC affiliate KTBS reports. What you should know: 1. Shreveport, ...20 March 2020 -
500. 3 updates to know for colorectal cancer awareness month
March is colorectal cancer awareness month. Here are three recent updates on colonoscopies and CRC screening: 1. Low-performing colonoscopists improved adenoma and serrated lesion detection rates when ...12 March 2020